P N Gadgil Jewellers profit and loss

Latest FY26
Revenue
₹10,739cr+39.6% on FY25
EBITDA
₹616cr+83.4% on FY25
Net profit
₹410cr+87.8% on FY25
EPS
₹30.20+76.6% on FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025
11,92610,7397,693
85.888.135.1
12,01210,8277,729
Expenses
10,4499,4376,990
179157112
12991.643.0
70.057.234.8
529529256
11,35610,2727,435
769616336
699559301
Profit
657555293
−3.4−3.40.0
653552293
17014574.2
−4.7−3.20.6
16614274.8
488410218
488410218
−1.8−0.5−0.4
486409218
487409218
Per share
₹35.69₹30.20₹17.10
₹35.69₹30.20₹17.10
Other comprehensive income — detail
−1.8−0.5−0.4
−2.4−0.7−0.5
−0.6−0.2−0.1
486409218
Per share — as-filed variants
₹35.69₹30.20₹17.10
₹35.69₹30.20₹17.10
Derived — gross profit (revenue − materials − purchases − Δ inventories)
1,4781,302704
12.4%12.1%9.1%
Adjusted (ex-exceptional items) — derived
657555293
−3.4−3.40.0
490412218
₹35.88₹30.39₹17.10
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PNGJL₹583.70

P N Gadgil Jewellers Ltd.

· Consumer Goods
AnnualQuarterly₹ CrorePeersKALYANKJILSENCOTITANPCJEWELLERREDTAPERELAXOSAFARISFLMcap ₹7,921 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue from Operations7,693.510,739.111,926.3
Other Income35.188.185.8
Total Income7,728.610,827.212,012.1
Expenses
+ Cost of Materials Consumed6,989.89,436.910,448.6
+ Employee Benefit Expense112.1157.2179.0
+ Finance Costs43.091.6128.5
+ Depreciation & Amortisation34.857.270.0
+ Other Expenses255.7529.0529.3
Total Expenses7,435.510,271.911,355.6
EBITDA335.8615.9769.3
EBIT301.0558.8699.3
Profit
PBT before Exceptional Items293.1555.3656.5
+ Exceptional Items0.0-3.4-3.4
Pretax Income293.1551.9653.1
+ Current Tax74.2145.2170.2
+ Deferred Tax0.6-3.2-4.7
Tax Expense74.8142.0165.5
Net Income218.3409.8487.6
+ Net Income — Continuing Ops218.3409.8487.6
+ Other Comprehensive Income-0.4-0.5-1.8
Total Comprehensive Income217.9409.3485.8
Net Income to Common218.3409.3487.5
Per Share
Basic EPS17.1030.2035.69
Diluted EPS17.1030.2035.69
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.4-0.5-1.8
+ Items NOT to be Reclassified to P&L-0.5-0.7-2.4
+ Tax on Items NOT to be Reclassified-0.1-0.2-0.6
Comprehensive Income — Owners of Parent217.9409.3485.9
Per Share — as-filed variants
Basic EPS — Continuing Operations17.1030.2035.69
Diluted EPS — Continuing Operations17.1030.2035.69
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit703.61,302.21,477.6
Gross Margin %9.1512.1312.39
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)293.1555.3656.5
− Exceptional Items (reconciliation)0.0-3.4-3.4
Net Income Adj (tax-effected)218.3412.3490.1
EPS Adj17.1030.3935.88
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Paid Up Equity Capital135.7135.7147.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.